The principal investigator of SLU's remdesivir trial explains how the antiviral drug works—and why it's a game-changer for COVID-19 patients

Dr. Sarah George has studied infectious diseases for almost 25 years, and she has seen pandemics before, including HIV, H1N1, Ebola, and Zika.


Subscribe to St. Louis Magazine's Culture newsletter to receive the latest news and recommendations from the arts scene.
Or, check out all of our newsletters.